Ana Velosa

Disease Spotlight

When faced with a devastating diagnosis, a family has two choices – to give up or make it their mission to adapt and carry on.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.